Laddar...
Treatment options in myocarditis and inflammatory cardiomyopathy: Focus on i. v. immunoglobulins
For myocarditis and inflammatory cardiomyopathy, an etiologically driven treatment is today the best option beyond heart failure therapy. Prerequisites for this are noninvasive and invasive biomarkers including endomyocardial biopsy and polymerase chain reaction on cardiotropic agents. Imaging by Do...
Sparad:
| I publikationen: | Herz |
|---|---|
| Huvudupphovsmän: | , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer Medizin
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6096625/ https://ncbi.nlm.nih.gov/pubmed/29947834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00059-018-4719-x |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|